ARWR
Arrowhead Pharmaceuticals, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Arrowhead Pharmaceuticals has 0 disclosed suppliers and 4 disclosed customers in SEC filings.
SentenceOn October 7, 2020, Takeda and the Company entered into an Exclusive License and Co-Funding Agreement (the "Takeda License Agreement").
ARWR 10-Kaccession 0000879407-25-000029
—
Last report3 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−2.99%
vs ±8.5% implied · ×0.35
shaded = implied · ▲▼ = realized
Arrowhead Pharmaceuticals, Inc.
60.49
0.00 · 0.00%
post 59.64 −1.41%
Linked news
Expected move
Inputsspot 59.90exp Dec 18ATM strike 60ATM straddle 9.20IV 53%